Xenograft recipients and the right to withdraw from a clinical trial.

Preclinical xenotransplantation research using genetically engineered pigs has begun to show some promising results and could one day offer a scalable means of addressing organ shortage. While it is a fundamental tenet of ethical human subject research that participants have a right to withdraw from...

Descripción completa

Detalles Bibliográficos

Publicado en:	Bioethics Vol. 38; no. 4; pp. 308 - 316
Autores principales:	Bobier, Christopher, Hurst, Daniel J., Rodger, Daniel, Omelianchuk, Adam
Formato:	Artículo
Publicado:	Wiley-Blackwell May2024
Materias:	Patients Patients' rights Human research subjects Termination of treatment Clinical trials Infectious disease transmission Public health Law Legislation Disease risk factors Transplantation of organs, tissues, etc. Xenografts Zoonoses Biosurveillance
Acceso en línea:	Ver este registro en EBSCOhost